Category Archives: ABBV

Abbott Labs Update

On September 19, 2012 (found here), we recommended that investors consider selling Abbott Labs (ABT), at least the principal portion.  At the time, ABT was trading at a split-adjusted $33.  by October 16, 2012, shortly after our sell recommendation, Abbott rose as high as $34.67 or +5.06%.

Continue reading